PMC:7405836 / 119881-120010 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T58","span":{"begin":38,"end":55},"obj":"Body_part"}],"attributes":[{"id":"A58","pred":"fma_id","subj":"T58","obj":"http://purl.org/sig/ont/fma/fma265130"}],"text":"Such drugs acting specifically in the respiratory tract will help to reduce virus-triggered immune pathologies in COVID-19 (209)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T133","span":{"begin":38,"end":55},"obj":"Body_part"}],"attributes":[{"id":"A133","pred":"uberon_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"}],"text":"Such drugs acting specifically in the respiratory tract will help to reduce virus-triggered immune pathologies in COVID-19 (209)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1053","span":{"begin":114,"end":122},"obj":"Disease"}],"attributes":[{"id":"A1053","pred":"mondo_id","subj":"T1053","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Such drugs acting specifically in the respiratory tract will help to reduce virus-triggered immune pathologies in COVID-19 (209)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T153","span":{"begin":76,"end":81},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Such drugs acting specifically in the respiratory tract will help to reduce virus-triggered immune pathologies in COVID-19 (209)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T270","span":{"begin":5,"end":10},"obj":"Chemical"}],"attributes":[{"id":"A270","pred":"chebi_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Such drugs acting specifically in the respiratory tract will help to reduce virus-triggered immune pathologies in COVID-19 (209)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T808","span":{"begin":0,"end":129},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Such drugs acting specifically in the respiratory tract will help to reduce virus-triggered immune pathologies in COVID-19 (209)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3262","span":{"begin":114,"end":122},"obj":"Disease"}],"attributes":[{"id":"A3262","pred":"tao:has_database_id","subj":"3262","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Such drugs acting specifically in the respiratory tract will help to reduce virus-triggered immune pathologies in COVID-19 (209)."}